AMP-independent activator of AMPK for treatment of mitochondrial disorders
Sign Up to like & getrecommendations! Published in 2020 at "PLoS ONE"
DOI: 10.1371/journal.pone.0240517
Abstract: Mitochondrial diseases are a clinically heterogenous group of disorders caused by respiratory chain dysfunction and associated with progressive, multi-systemic phenotype. There is no effective treatment or cure, and no FDA-approved drug for treating mitochondrial disease.… read more here.
Keywords: independent activator; amp independent; treatment mitochondrial; treatment ... See more keywords